Belgium· BE-AMP-SAM570275-00
Idefirix 11 mg
A imlifidase product containing imlifidase, registered in Belgium by Hansa Biopharma. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Imlifidase is registered in 12 of 19 countries.
Countries holding a registration under ATC L04AA41 (imlifidase), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Imlifidase · ATC L04AA41
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of imlifidase costs, country by country.
Normalised to the WHO defined daily dose (17.5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Imlifidase · price per daily dose (17.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$271803.14
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Imlifidase
- Manufacturer
- Hansa Biopharma
- Country
- Belgium (BE)
- ATC code
- L04AA41
- ATC class
- Imlifidase
- Defined daily dose
- 17.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb4420550
- be_apb7738024
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Imlifidase in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaIDEFIRIXHansa Biopharma AB, Lund
- SpainIDEFIRIX 11 MG DE POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONHansa Biopharma Ab
- FinlandIdefirixHansa Biopharma AB
- United KingdomIdefirix 11mg powder for concentrate for solution for infusion vialsHansa Biopharma AB
- IrelandIdefirix 11 mg powder for concentrate for solution for infusionHansa Biopharma AB
- IcelandIdefirixHansa Biopharma AB
- NorwayIdefirixHansa Biopharma AB
- PolandIdefirixHansa Biopharma AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Idefirix
- Liechtenstein · Idefirix
- Norway · Idefirix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0036e68d-7e35-4792-a64d-08f20c14c3a1 GET /v1/drugs/0036e68d-7e35-4792-a64d-08f20c14c3a1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for concentrate for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Idefirix 11 mg",
"name_fr": "Idefirix 11 mg",
"name_nl": "Idefirix 11 mg",
"amp_code": "SAM570275-00",
"strengths": [
"11.0000"
],
"pack_count": 2,
"substances": [
"Imlifidase",
"Disodium Edetate Dihydrate",
"Mannitol",
"Polysorbate 80"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Imlifidase",
"authorisation_numbers": [
"EU/1/20/1471/001",
"EU/1/20/1471/002"
]
}See everything about imlifidase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.